Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
17 Apr 2024
Historique:
received: 23 06 2023
accepted: 18 03 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: aheadofprint

Résumé

We report a multi-ancestry genome-wide association study on liver cirrhosis and its associated endophenotypes, alanine aminotransferase (ALT) and γ-glutamyl transferase. Using data from 12 cohorts, including 18,265 cases with cirrhosis, 1,782,047 controls, up to 1 million individuals with liver function tests and a validation cohort of 21,689 cases and 617,729 controls, we identify and validate 14 risk associations for cirrhosis. Many variants are located near genes involved in hepatic lipid metabolism. One of these, PNPLA3 p.Ile148Met, interacts with alcohol intake, obesity and diabetes on the risk of cirrhosis and hepatocellular carcinoma (HCC). We develop a polygenic risk score that associates with the progression from cirrhosis to HCC. By focusing on prioritized genes from common variant analyses, we find that rare coding variants in GPAM associate with lower ALT, supporting GPAM as a potential target for therapeutic inhibition. In conclusion, this study provides insights into the genetic underpinnings of cirrhosis.

Identifiants

pubmed: 38632349
doi: 10.1038/s41588-024-01720-y
pii: 10.1038/s41588-024-01720-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Luca A Lotta (LA)

Informations de copyright

© 2024. The Author(s).

Références

Ginès, P. et al. Liver cirrhosis. Lancet Lond. Engl. 398, 1359–1376 (2021).
doi: 10.1016/S0140-6736(21)01374-X
Huang, D. Q. et al. Global epidemiology of cirrhosis—aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20, 388–398 (2023).
pubmed: 36977794 pmcid: 10043867 doi: 10.1038/s41575-023-00759-2
Loomba, R. et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 149, 1784–1793 (2015).
pubmed: 26299412 doi: 10.1053/j.gastro.2015.08.011
Emdin, C. A. et al. Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene–environment interaction study. Gastroenterology 160, 1620–1633 (2021).
pubmed: 33310085 doi: 10.1053/j.gastro.2020.12.011
Gellert-Kristensen, H. et al. Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population. Hepatology 72, 845–856 (2020).
pubmed: 32190914 doi: 10.1002/hep.31238
Abul-Husn, N. S. et al. A protein-truncating HSD17B13 variant and protection from chronic liver disease. N. Engl. J. Med. 378, 1096–1106 (2018).
pubmed: 29562163 pmcid: 6668033 doi: 10.1056/NEJMoa1712191
Emdin, C. A. et al. A missense variant in mitochondrial amidoxime reducing component 1 gene and protection against liver disease. PLoS Genet. 16, e1008629 (2020).
pubmed: 32282858 pmcid: 7200007 doi: 10.1371/journal.pgen.1008629
Schneider, C. V. et al. A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. Med 2, 851–863 (2021).
pubmed: 34258604 doi: 10.1016/j.medj.2021.04.011
Verweij, N. et al. Germline mutations in CIDEB and protection against liver disease. N. Engl. J. Med. 387, 332–344 (2022).
pubmed: 35939579 doi: 10.1056/NEJMoa2117872
Buch, S. et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat. Genet. 47, 1443–1448 (2015).
pubmed: 26482880 doi: 10.1038/ng.3417
Stender, S. et al. Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci. Nat. Genet. 49, 842–847 (2017).
pubmed: 28436986 pmcid: 5562020 doi: 10.1038/ng.3855
GTEX ConsortiumThe GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
doi: 10.1126/science.aaz1776
Mikaelsdottir, E. et al. Genetic variants associated with platelet count are predictive of human disease and physiological markers. Commun. Biol. 4, 1–13 (2021).
doi: 10.1038/s42003-021-02642-9
Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712–1721 (2021).
pubmed: 34857953 doi: 10.1038/s41588-021-00978-w
Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329–338 (2023).
Akbari, P. et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat. Commun. 13, 4844 (2022).
pubmed: 35999217 pmcid: 9399235 doi: 10.1038/s41467-022-32398-7
Lotta, L. A. et al. Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors. JAMA 320, 2553–2563 (2018).
pubmed: 30575882 pmcid: 6583513 doi: 10.1001/jama.2018.19329
Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166–174 (2019).
pubmed: 30239722 doi: 10.1093/hmg/ddy327
Cho, Y. et al. Genetic influences on alcohol flushing in East Asian population. BMC Genomics 24, 638 (2023).
Sveinbjornsson, G. et al. Multiomics study of nonalcoholic fatty liver disease. Nat. Genet. 54, 1652–1663 (2022).
pubmed: 36280732 pmcid: 9649432 doi: 10.1038/s41588-022-01199-5
Jamialahmadi, O. et al. Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease. Gastroenterology 160, 1634–1646 (2021).
pubmed: 33347879 doi: 10.1053/j.gastro.2020.12.023
Hakim, A. et al. Genetic variation in the mitochondrial glycerol-3-phosphate acyltransferase is associated with liver injury. Hepatology 74, 3394–3408 (2021).
pubmed: 34216018 doi: 10.1002/hep.32038
Vujkovic, M. et al. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat. Genet. 54, 761–771 (2022).
pubmed: 35654975 pmcid: 10024253 doi: 10.1038/s41588-022-01078-z
Koyama, S. et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat. Genet. 52, 1169–1177 (2020).
pubmed: 33020668 doi: 10.1038/s41588-020-0705-3
Márquez-Luna, C., Loh, P.-R. & Price, A. L. South Asian Type 2 Diabetes (SAT2D) Consortium, SIGMA Type 2 Diabetes Consortium Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol. 41, 811–823 (2017).
pubmed: 29110330 pmcid: 5726434 doi: 10.1002/gepi.22083
Kurniansyah, N. et al. A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood. Nat. Commun. 13, 3549 (2022).
pubmed: 35729114 pmcid: 9213527 doi: 10.1038/s41467-022-31080-2
Ge, T. et al. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. Genome Med. 14, 70 (2022).
pubmed: 35765100 pmcid: 9241245 doi: 10.1186/s13073-022-01074-2
Kamatani, Y. et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41, 591–595 (2009).
pubmed: 19349983 doi: 10.1038/ng.348
Westerman, K. E. et al. Variance-quantitative trait loci enable systematic discovery of gene–environment interactions for cardiometabolic serum biomarkers. Nat. Commun. 13, 3993 (2022).
pubmed: 35810165 pmcid: 9271055 doi: 10.1038/s41467-022-31625-5
Lyon, M. S., Millard, L. A. C., Smith, G. D., Gaunt, T. R. & Tilling, K. Hypothesis-free detection of gene-interaction effects on biomarker concentration in UK Biobank using variance prioritisation. Preprint at medRxiv https://doi.org/10.1101/2022.01.05.21268406 (2022).
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Nielsen, J. B. et al. Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. Nat. Commun. 11, 6417 (2020).
pubmed: 33339817 pmcid: 7749177 doi: 10.1038/s41467-020-20086-3
Pazoki, R. et al. Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes. Nat. Commun. 12, 2579 (2021).
pubmed: 33972514 pmcid: 8110798 doi: 10.1038/s41467-021-22338-2
El-Serag, H. B. et al. Risk factors for cirrhosis in contemporary hepatology practices—findings from Texas Hepatocellular Carcinoma Consortium Cohort. Gastroenterology 159, 376–377 (2020).
pubmed: 32234536 doi: 10.1053/j.gastro.2020.03.049
Davies, N. M., Holmes, M. V. & Smith, G. D. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362, k601 (2018).
pubmed: 30002074 pmcid: 6041728 doi: 10.1136/bmj.k601
McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
pubmed: 27268795 pmcid: 4893825 doi: 10.1186/s13059-016-0974-4
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
pubmed: 24830394 pmcid: 4022491 doi: 10.1371/journal.pgen.1004383
Wallace, C. Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses. PLoS Genet. 16, e1008720 (2020).
pubmed: 32310995 pmcid: 7192519 doi: 10.1371/journal.pgen.1008720
Weeks, E. M. et al. Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. Nat. Genet. 55, 1267–1276 (2023).
De Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657 doi: 10.1371/journal.pcbi.1004219
Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628–634 (2021).
pubmed: 34662886 pmcid: 8596853 doi: 10.1038/s41586-021-04103-z
Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097–1103 (2021).
pubmed: 34017140 doi: 10.1038/s41588-021-00870-7
Ge, T., Chen, C.-Y., Ni, Y., Feng, Y.-C. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
pubmed: 30992449 pmcid: 6467998 doi: 10.1038/s41467-019-09718-5
Lee, S. H., Goddard, M. E., Wray, N. R. & Visscher, P. M. A better coefficient of determination for genetic profile analysis. Genet. Epidemiol. 36, 214–224 (2012).
pubmed: 22714935 doi: 10.1002/gepi.21614
Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).
pubmed: 21414208 pmcid: 3068975 doi: 10.1186/1471-2105-12-77
Aalen, O. O. & Johansen, S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand. J. Stat. 5, 141–150 (1978).

Auteurs

Jonas Ghouse (J)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. jonasghouse@gmail.com.
Cardiac Genetics Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. jonasghouse@gmail.com.

Gardar Sveinbjörnsson (G)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Marijana Vujkovic (M)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Anne-Sofie Seidelin (AS)

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Helene Gellert-Kristensen (H)

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Gustav Ahlberg (G)

Cardiac Genetics Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Vinicius Tragante (V)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Søren A Rand (SA)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Cardiac Genetics Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Joseph Brancale (J)

Section of Digestive Diseases, Department of Internal Medicine, and Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

Silvia Vilarinho (S)

Section of Digestive Diseases, Department of Internal Medicine, and Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

Pia Rengtved Lundegaard (PR)

Cardiac Genetics Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Erik Sørensen (E)

Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Christian Erikstrup (C)

Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.

Mie Topholm Bruun (MT)

Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.

Bitten Aagaard Jensen (BA)

Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.

Søren Brunak (S)

Translational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Karina Banasik (K)

Department of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark.

Henrik Ullum (H)

Statens Serum Institut, Copenhagen, Denmark.

Niek Verweij (N)

Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Luca Lotta (L)

Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Aris Baras (A)

Regeneron Genetics Center, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.

Tooraj Mirshahi (T)

Department of Molecular and Functional Genomics, Geisinger Health System, Danville, PA, USA.

David J Carey (DJ)

Department of Molecular and Functional Genomics, Geisinger Health System, Danville, PA, USA.

David E Kaplan (DE)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Julie Lynch (J)

VA Informatics and Computing Infrastructure (VINCI), VA Salt Lake City Health Care System, Salt Lake City, UT, USA.
Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.

Timothy Morgan (T)

Gastroenterology Section, Veterans Affairs Long Beach Healthcare System, Long Beach, CA, USA.
Department of Medicine, University of California, Irvine, CA, USA.

Tae-Hwi Schwantes-An (TH)

Gastroenterology Section, Veterans Affairs Long Beach Healthcare System, Long Beach, CA, USA.
Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA.

Daniel R Dochtermann (DR)

Center for Data and Computational Sciences, VA Boston Healthcare System, Boston, MA, USA.

Saiju Pyarajan (S)

Center for Data and Computational Sciences, VA Boston Healthcare System, Boston, MA, USA.
Department of Medicine, Brigham Women's Hospital and Harvard Medical School, Boston, MA, USA.

Philip S Tsao (PS)

Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto, Palo Alto, CA, USA.
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Triin Laisk (T)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.

Reedik Mägi (R)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.

Julia Kozlitina (J)

Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Anne Tybjærg-Hansen (A)

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

David Jones (D)

Precision Genomics, Intermountain Healthcare, Saint George, UT, USA.

Kirk U Knowlton (KU)

Intermountain Medical Center, Intermountain Heart Institute, Salt Lake City, UT, USA.
University of Utah, School of Medicine, Salt Lake City, UT, USA.

Lincoln Nadauld (L)

Precision Genomics, Intermountain Healthcare, Saint George, UT, USA.
Stanford University, School of Medicine, Stanford, CA, USA.

Egil Ferkingstad (E)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Einar S Björnsson (ES)

Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.

Magnus O Ulfarsson (MO)

deCODE Genetics/Amgen, Reykjavik, Iceland.
Faculty of Electrical and Computer Engineering, University of Iceland, Reykjavik, Iceland.

Árni Sturluson (Á)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Patrick Sulem (P)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Ole B Pedersen (OB)

Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.

Sisse R Ostrowski (SR)

Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Daniel F Gudbjartsson (DF)

deCODE Genetics/Amgen, Reykjavik, Iceland.
School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.

Kari Stefansson (K)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Morten Salling Olesen (MS)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Cardiac Genetics Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

Kyong-Mi Chang (KM)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Hilma Holm (H)

deCODE Genetics/Amgen, Reykjavik, Iceland.

Henning Bundgaard (H)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Stefan Stender (S)

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. stefan.stender@regionh.dk.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. stefan.stender@regionh.dk.

Classifications MeSH